Drug discovery hit to lead

Drug discovery hit to lead

Early drug discovery involves several phases from target identification to preclinical development. The identification of small molecule modulators of protein function and the process of transforming these into high-content lead series are key activities in modern drug discovery.[1] The Hit-to-Lead phase is usually the follow-up of high-throughput screening (HTS). It includes the following steps:

Contents

Hit confirmation

The Hit confirmation phase will be performed during several weeks as follows:

  • Re-testing: compounds that were found active against the selected target are re-tested using the same assay conditions used during the HTS.
  • Dose response curve generation: several compound concentrations are tested using the same assay, an IC50 or EC50 value is then generated. Methods are being developed that may allow the reuse of the compound that generated the hit in the initial HTS step. These molecules are removed from beads and transferred to a microarray for quantitative assessment of binding affinities in a "seamless" approach that could allow for the investigation of more hits and larger libraries.[2][3]
  • Orthogonal testing: Confirmed hits are assayed using a different assay which is usually closer to the target physiological condition or using a different technology.
  • Secondary screening: Confirmed hits are tested in a functional assay or in a cellular environment. Membrane permeability is usually a critical parameter.
  • Chemical amenability: Medicinal chemists will evaluate compounds according to their synthesis feasibility and other parameters such as up-scaling or costs
  • Intellectual property evaluation: Hit compound structures are quickly checked in specialized databases to define patentability
  • Biophysical testing: Nuclear magnetic resonance (NMR), Isothermal Titration Calorimetry, dynamic light scattering, surface plasmon resonance, dual polarisation interferometry, microscale thermophoresis (MST) are commonly used to assess whether the compound binds effectively to the target, the stoïchiometry of binding, any associated conformational change and to identify promiscuous inhibitors.
  • Hit ranking and clustering: Confirmed hit compounds are then ranked according to the various hit confirmation experiments.

Hit expansion

Following hit confirmation, several compound clusters will be chosen according to their characteristics in the previously defined tests. An Ideal compound cluster will:

  • have compound members that exhibit a high affinity towards the target (less than 1 µM)
  • Moderate molecular weight and lipophilicity (usually measured as cLogP). Affinity, molecular weight and lipophilicity can be linked in single parameter such as ligand efficiency and lipophilic efficiency to assess druglikeness
  • show chemical tractability
  • be free of Intellectual property
  • not interfere with the P450 enzymes nor with the P-glycoproteins
  • not bind to human serum albumin
  • be soluble in water(above 100 µM)
  • be stable
  • have a good druglikeness
  • exhibit cell membrane permeability
  • show significant biological activity in a cellular assay
  • not exhibit cytotoxicity
  • not be metabolized rapidly
  • show selectivity versus other related targets

The project team will usually select between three and six compound series to be further explored. The next step will allow to test analogous compounds to define Quantitative structure-activity relationship (QSAR). Analogs can be quickly selected from an internal library or purchased from commercially available sources. Medicinal chemists will also start synthesizing related compounds using different methods such as combinatorial chemistry, high-throughput chemistry or more classical organic chemistry synthesis.

Lead optimization phase

The objective of this drug discovery phase is to synthesize lead compounds, new analogs with improved potency, reduced off-target activities, and physiochemical/metabolic properties suggestive of reasonable in vivo pharmacokinetics. This optimization is accomplished through chemical modification of the hit structure, with modifications chosen by employing structure-activity analysis (SAR) as well as structure-based design if structural information about the target is available.

See also

References

  1. ^ Bleicher KH, et.al. Nat Rev Drug Discov. 2003 May; 2(5):369-78.
  2. ^ Astle, J. M.; Simpson, L. S.; Huang, Y.; Reddy, M. M.; Wilson, R.; Connell, S.; Wilson, J.; Kodadek, T. (2010). "Seamless Bead to Microarray Screening: Rapid Identification of the Highest Affinity Protein Ligands From Large Combinatorial Libraries". Chemistry & Biology 17 (1): 38–45. doi:10.1016/j.chembiol.2009.12.015. PMC 2905650. PMID 20142039. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2905650.  edit
  3. ^ Science Daily article on bead to microarray screening method

Wikimedia Foundation. 2010.

Игры ⚽ Поможем решить контрольную работу

Look at other dictionaries:

  • Drug discovery — In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are discovered and/or designed. In the past most drugs have been discovered either by identifying the active ingredient from traditional… …   Wikipedia

  • Drug Discovery Today — (ISSN 1359 6446) is a monthly review journal that is published by Elsevier and was launched in 1996. The journal publishes 24 issues per year as 12 monthly double issues, and covers the whole of the preclinical drug discovery process from target… …   Wikipedia

  • Discovery and development of nucleoside and nucleotide reverse-transcriptase inhibitors — (NRTIs and NtRTIs) began in the 1980s when the AIDS epidemic hit Western societies. NRTIs inhibit the reverse transcriptase (RT), an enzyme that controls the replication of the genetic material of the human immunodeficiency virus (HIV). The first …   Wikipedia

  • Discovery and development of dual serotonin and norepinephrine reuptake inhibitors — Serotonin–norepinephrine reuptake inhibitors (SNRIs) are a class of antidepressant drugs used in the treatment of major depressive disorder (MDD). SNRIs are potent inhibitors of serotonin (5 Hydroxytryptamine, 5 HT) and norepinephrine (NE,… …   Wikipedia

  • Discovery and development of cyclooxygenase 2 inhibitors — Cyclooxygenases are enzymes that take part in a complex biosynthetic cascade that results in the conversion of polyunsaturated fatty acids to prostaglandins and thromboxane(s).[1] Their main role is to catalyze the transformation of arachidonic… …   Wikipedia

  • Discovery and development of TRPV1 antagonists — Chronic pain remains a recognized unmet medical need. Consequently, the search for new analgesic agents is being intensively studied by the pharmaceutical industry. The TRPV1 receptor is an ion channel that has been implicated in mediation of… …   Wikipedia

  • Discovery and development of antiandrogens — In the 1960s, the first antiandrogen, or androgen antagonist, was discovered. Antiandrogens antagonise the androgen receptor (AR) and thereby block the biological effects of testosterone and dihydrotestosterone (DHT). Antiandrogens are important… …   Wikipedia

  • Lead compound — A lead compound (i.e. the leading compound, not lead metal) in drug discovery is a chemical compound that has pharmacological or biological activity and whose chemical structure is used as a starting point for chemical modifications in order to… …   Wikipedia

  • Discovery and development of triptans — Triptans is a word commonly used for a class of anti migraine drugs that are selective 5 hydroxytryptamine/serotonin1B/1D (5 HT1B/1D) agonists.[1] Migraine is a complex disease which affects about 15% of the population and can be highly disabling …   Wikipedia

  • Discovery and development of cephalosporins — Cephalosporins are a broad class of bactericidal antibiotics that include the β lactam ring and share a structural similarity and mechanism of action with other β lactam antibiotics (e.g. penicillins, carbapenems and aztreonam).[1] The… …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”